Cargando…
TIMP1 Indicates Poor Prognosis of Renal Cell Carcinoma and Accelerates Tumorigenesis via EMT Signaling Pathway
Renal cell carcinoma (RCC) is one of the most common malignancies in the urinary system. The mortality of advanced RCC remains high despite advances in systemic therapy of RCC. Considering the misdiagnosis of early-stage RCC, the identification of effective biomarkers is of great importance. Tissue...
Autores principales: | Shou, Yi, Liu, Yuenan, Xu, Jiaju, Liu, Jingchong, Xu, Tianbo, Tong, Junwei, Liu, Lilong, Hou, Yaxin, Liu, Di, Yang, Hongmei, Cheng, Gong, Zhang, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914045/ https://www.ncbi.nlm.nih.gov/pubmed/35281807 http://dx.doi.org/10.3389/fgene.2022.648134 |
Ejemplares similares
-
The Identification of Critical m(6)A RNA Methylation Regulators as Malignant Prognosis Factors in Prostate Adenocarcinoma
por: Xu, Jiaju, et al.
Publicado: (2020) -
Low Expression Levels of SLC22A12 Indicates a Poor Prognosis and Progresses Clear Cell Renal Cell Carcinoma
por: Xu, Jiaju, et al.
Publicado: (2021) -
METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma
por: Xu, Tianbo, et al.
Publicado: (2021) -
circPTPN12 promotes the progression and sunitinib resistance of renal cancer via hnRNPM/IL-6/STAT3 pathway
por: Shou, Yi, et al.
Publicado: (2023) -
A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma
por: Gao, Su, et al.
Publicado: (2021)